Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.

Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP.

Clin Cancer Res. 2002 Jan;8(1):131-7.

2.
3.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

4.

[Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].

Nakatsuka S, Takakuwa T, Aozasa K.

Rinsho Byori. 2001 Dec;49(12):1242-7. Review. Japanese.

PMID:
11797395
5.

DNA methylation changes and multiple myeloma.

Ng MH, Wong IH, Lo KW.

Leuk Lymphoma. 1999 Aug;34(5-6):463-72. Review.

PMID:
10492069
6.
7.

Promoter hypermethylation patterns of P16, DAPK and MGMT in oral squamous cell carcinoma: a systematic review and meta-analysis.

Don KR, Ramani P, Ramshankar V, Sherlin HJ, Premkumar P, Natesan A.

Indian J Dent Res. 2014 Nov-Dec;25(6):797-805. doi: 10.4103/0970-9290.152208. Review.

8.

Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.

Ye M, Huang T, Ni C, Yang P, Chen S.

EBioMedicine. 2017 Apr;18:32-40. doi: 10.1016/j.ebiom.2017.03.038. Epub 2017 Apr 2. Review.

9.

Alterations in DNA methylation: a fundamental aspect of neoplasia.

Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP.

Adv Cancer Res. 1998;72:141-96. Review.

PMID:
9338076
10.

Tumor suppressor genes in lung cancer.

Virmani AK, Gazdar AF.

Methods Mol Biol. 2003;222:97-115. Review. No abstract available.

PMID:
12710682
11.

Epigenetic disruption of cell signaling in nasopharyngeal carcinoma.

Li LL, Shu XS, Wang ZH, Cao Y, Tao Q.

Chin J Cancer. 2011 Apr;30(4):231-9. Review.

12.

[Functional genomics of nasopharyngeal carcinoma susceptibility/suppressor gene].

Li XL, Wu MH, Li GY.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Jul;33(7):553-8. Review. Chinese.

13.

DAP kinase-a proapoptotic gene that functions as a tumor suppressor.

Raveh T, Kimchi A.

Exp Cell Res. 2001 Mar 10;264(1):185-92. Review. No abstract available.

PMID:
11237533
14.

DNA Methylation Biomarkers for Nasopharyngeal Carcinoma: Diagnostic and Prognostic Tools.

Jiang W, Cai R, Chen QQ.

Asian Pac J Cancer Prev. 2015;16(18):8059-65. Review.

15.

Methylation in oral cancer and pre-cancerous lesions (Review).

Díez-Pérez R, Campo-Trapero J, Cano-Sánchez J, López-Durán M, Gonzalez-Moles MA, Bascones-Ilundain J, Bascones-Martinez A.

Oncol Rep. 2011 May;25(5):1203-9. doi: 10.3892/or.2011.1205. Epub 2011 Mar 4. Review.

PMID:
21380489
16.

The association of retinoic acid receptor beta2(RARβ2) methylation status and prostate cancer risk: a systematic review and meta-analysis.

Gao T, He B, Pan Y, Li R, Xu Y, Chen L, Nie Z, Gu L, Wang S.

PLoS One. 2013 May 13;8(5):e62950. doi: 10.1371/journal.pone.0062950. Print 2013. Review.

17.

[Progress of RASSF1A gene in neoplasms].

Xing XS, Huang LM, Ma XD.

Zhonghua Bing Li Xue Za Zhi. 2004 Dec;33(6):562-4. Review. Chinese. No abstract available.

PMID:
15634458
18.

Deciphering the molecular genetic basis of NPC through functional approaches.

Lung HL, Cheung AK, Ko JM, Cheng Y, Stanbridge EJ, Lung ML.

Semin Cancer Biol. 2012 Apr;22(2):87-95. doi: 10.1016/j.semcancer.2011.11.002. Epub 2011 Dec 2. Review.

PMID:
22154888
19.

Tumor suppressor NGX6 inhibits the growth and metastasis of multiple cancers.

He S, Zhong Y, Shuai C, Gao D, Wei P, Li G, Peng S.

Tumour Biol. 2016 May;37(5):5751-60. doi: 10.1007/s13277-016-4966-5. Epub 2016 Feb 15. Review.

PMID:
26880583
20.

Haplo-insufficiency? Let me count the ways.

Quon KC, Berns A.

Genes Dev. 2001 Nov 15;15(22):2917-21. Review. No abstract available.

Supplemental Content

Support Center